Dark

Check out our Dark Pool Levels

PKI
PERKINELMER INC
stock NYSE

Inactive

May 15, 2023

115.24USD-0.911%(-1.06)1,633,026

Pre-market

0.00USD-100.000%(-116.30)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 31, 2022

10:42AM EST PerkinElmer Earnings Preview Benzinga

Jan 27, 2022

04:18PM EST PerkinElmer (PKI) Declares Quarterly Dividend of $ 0.07, Record Date 4/22/2022 RTTNews

04:15PM EST PerkinElmer Board Declares Quarterly Dividend Business Wire

Jan 18, 2022

05:51PM EST January 18, at 4:00pm MDT (6:00pm EDT) to discuss its announced acquisition of M&M Food Market PR Newswire

05:00PM EST Parkland expands food offer and accelerates convenience growth with acquisition PR Newswire

Jan 12, 2022

05:30PM EST Parkland Corporation Announces January 2022 Dividend PR Newswire

Jan 11, 2022

11:07AM EST Shares of Diagnostics & Research company PerkinElmer, Inc. (PKI) are falling more than 5% Monday morning despite providing fourth-quarter outlook, better than analysts' view. RTTNews

07:08AM EST PerkinElmer, Inc. (PKI), a science and healthcare company, Tuesday said it expects fourth-quarter adjusted earnings per share from continuing operations to be at least $2.40. RTTNews

06:34AM EST PerkinElmer Says Expects Q4 Adj. EPS From Cont. Ops. Of At Least $2.40 RTTNews

06:34AM EST PerkinElmer Sees Q4 Adj. EPS $2.40+ vs $2.12 Est., Sees COVID-Related Revenues ~$320M Benzinga

06:32AM EST PerkinElmer Expects Q4 Revenue And EPS To Exceed Prior Guidance Benzinga

06:30AM EST PerkinElmer Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, February 1, 2022 Business Wire

Dec 21, 2021

08:00AM EST PerkinElmer to Present Virtually at J.P. Morgan Healthcare Conference Business Wire

Dec 14, 2021

06:00PM EST Parkland ramps-up processing operations at the Burnaby Refinery PR Newswire

02:11PM EST Carterra, PerkinElmer Sign Distribution Agreement For Asia-Pacific And Oceania Region For Carterra's High Throughput Antibody Screening And Characterization Solutions Benzinga

08:22AM EST Wells Fargo Maintains Overweight on PerkinElmer, Raises Price Target to $205 Benzinga

Dec 13, 2021

06:49PM EST Parkland Corporation Announces December 2021 Dividend PR Newswire

Dec 8, 2021

08:29AM EST PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 To Strengthen SARS-CoV-2 Surveillance Benzinga

08:14AM EST PerkinElmer Announces Research Use Only Launch Of NEXTFLEX RTTNews

08:04AM EST PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit V2 RTTNews

08:00AM EST PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to Strengthen SARS-CoV-2 Surveillance Business Wire

Nov 30, 2021

05:06PM EST Parkland to expand its Canadian convenience and retail fuel network with PR Newswire

04:31PM EST PerkinElmer Confirms That Omicron Variant Does Not Impact SARS-CoV-2 Detection Capability Of Its RT-PCR Assays Benzinga

Nov 29, 2021

07:01AM EST Parkland Announces Normal Course Issuer Bid PR Newswire

Nov 23, 2021

06:49PM EST Parkland Announces Closing of Senior Unsecured Notes Offering PR Newswire

Nov 22, 2021

08:19PM EST Parkland initiates steps to pause refinery processing operations in response to PR Newswire

Nov 16, 2021

08:00AM EST PerkinElmer to Present at Evercore ISI HealthCONx Conference 2021 Business Wire

07:01AM EST Parkland's strategy to drive sustainable growth through the energy transition PR Newswire

Nov 12, 2021

05:29PM EST Parkland Corporation Clarifies Details Regarding November 2021 Dividend PR Newswire

12:16PM EST Here's How Much $100 Invested In PerkinElmer 10 Years Ago Would Be Worth Today Benzinga

Nov 11, 2021

05:30PM EST Parkland Corporation Announces November 2021 Dividend PR Newswire

05:05PM EST Parkland strengthens retail convenience network and supply advantage with PR Newswire

Nov 8, 2021

11:27PM EST Parkland Announces Pricing of US$800 Million Offering of Senior Unsecured Notes PR Newswire

07:26AM EST Parkland Announces US$500 Million Offering of Senior Unsecured Notes PR Newswire

Nov 5, 2021

08:00AM EDT PerkinElmer to Present at 2021 Stifel Healthcare Conference Business Wire

Nov 3, 2021

10:56AM EDT PerkinElmer Q3 Earnings, FY21 Guidance Beat Wall Street Expectations Benzinga

09:16AM EDT Wells Fargo Maintains Overweight on PerkinElmer, Raises Price Target to $200 Benzinga

07:02AM EDT Parkland grows U.S. retail business by over 90 percent with acquisition in the PR Newswire

Nov 2, 2021

08:28PM EDT Parkland delivers record third quarter results with Adjusted EBITDA of $364 PR Newswire

05:49PM EDT PerkinElmer Sees FY21 Sales $4.9B vs $4.65B Estimate, Adj. EPS $10.81 vs $10.07 Est. Benzinga

05:48PM EDT PerkinElmer Sees Q4 Sales ~$1.2B vs $1.07B Estimate, Adj. EPS $2.05 vs $1.74 Est. Benzinga

05:47PM EDT PerkinElmer Q3 Adj. EPS $2.31 Beats $1.71 Estimate, Sales $1.17B Beat $1.04B Estimate Benzinga

05:33PM EDT PerkinElmer: Q3 Earnings Insights Benzinga

05:31PM EDT Recap: PerkinElmer Q3 Earnings Benzinga

04:25PM EDT PerkinElmer Q3 EPS $1.11 Vs. $1.57 Year Ago RTTNews

04:15PM EDT PerkinElmer (PKI) reported a profit for third quarter that dropped from last year. RTTNews

04:08PM EDT PerkinElmer Announces Financial Results for the Third Quarter of 2021 Business Wire

10:41AM EDT Earnings Scheduled For November 2, 2021 Benzinga

Nov 1, 2021

08:04AM EDT PerkinElmer Releases 2021 Corporate Social Responsibility Report RTTNews

Oct 27, 2021

04:21PM EDT PerkinElmer (PKI) Declares Quarterly Dividend of $ 0.07, Record Date 1/21/2022 RTTNews

04:17PM EDT PerkinElmer Board Declares Quarterly Dividend Business Wire

Oct 18, 2021

08:15AM EDT PerkinElmer And Honeycomb Biotechnologies Launch The HIVE scRNAseq Solution For Single-Cell Analysis Benzinga

08:08AM EDT PerkinElmer And Honeycomb Biotechnologies Launch HIVE ScRNAseq Solution For Single-Cell Analysis RTTNews

08:00AM EDT PerkinElmer and Honeycomb Biotechnologies Launch the HIVE scRNAseq Solution for Single-Cell Analysis Business Wire

Oct 14, 2021

05:15PM EDT Parkland announces date of 2021 Third Quarter Results and opens registration PR Newswire

Oct 13, 2021

05:30PM EDT Parkland Corporation Announces October 2021 Dividend PR Newswire

Oct 12, 2021

04:15PM EDT PerkinElmer Schedules Earnings Call for Tuesday, November 2, 2021 Business Wire

Oct 7, 2021

08:47AM EDT PerkinElmer Inc. (PKI) said Thursday that it has received an emergency use authorization from the U.S. Food and Drug Administration for the PKamp Respiratory SARS-CoV-2 RT-PCR Panel 1 assay. RTTNews

08:34AM EDT PerkinElmer: FDA Issues Emergency Use Authorization For PKamp Respiratory SARS-CoV-2 RT-PCR Panel 1 Assay RTTNews

08:31AM EDT PerkinElmer Reports Received FDA Emergency Use Authorization For Respiratory SARS-CoV-2 Panel Benzinga

08:30AM EDT PerkinElmer Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel Business Wire

Oct 5, 2021

04:32PM EDT PerkinElmer, Inc.'s EUROIMMUN Announces FDA Has Provided EUA For Its Anti-SARS-CoV-2 S1 Curve ELISA (IgG) Benzinga

04:30PM EDT EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA Receives FDA Emergency Use Authorization Business Wire

Sep 22, 2021

09:53AM EDT PKI Mount Sinai Health System And PerkinElmer Collaborate To Accelerate COVID-19 Screening Benzinga

Sep 17, 2021

04:43PM EDT PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend Business Wire

Sep 13, 2021

05:05PM EDT Parkland Corporation (Parkland) (TSX:PKI) announces that a dividend of $0.1029 per share will be paid on October 15, 2021 to shareholders of record on September 22, 2021. The dividend will be an 'eligible dividend' for Canadian income tax purposes. The ex-dividend date is September 21, 2021. GlobeNewswire Inc

Sep 8, 2021

10:37PM EDT PerkinElmer Says Prices Offering Of Senior Notes RTTNews

10:30PM EDT PerkinElmer Prices Offering of Senior Notes Business Wire

Aug 26, 2021

05:40AM EDT PerkinElmer Announces $1.5B Credit Facility Deal Benzinga

Aug 24, 2021

08:00AM EDT PerkinElmer to Present at 2021 Baird Global Healthcare Conference Business Wire

Aug 11, 2021

05:05PM EDT Parkland Corporation (Parkland) (TSX:PKI) announces that a dividend of $0.1029 per share will be paid on September 15, 2021 to shareholders of record on August 20, 2021. The dividend will be an 'eligible dividend' for Canadian income tax purposes. The ex-dividend date is August 19, 2021. GlobeNewswire Inc

Aug 5, 2021

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Jul 26, 2021

08:19AM EDT PerkinElmer To Acquire Lifescience Firm BioLegend For $5B; Q2 Earnings Beat Estimates Benzinga

07:06AM EDT While reporting financial results for the second quarter on Monday, healthcare company PerkinElmer, Inc. (PKI) raised its adjusted earnings and adjusted revenue guidance for the full-year 2021. The company also provided outlook for the third quarter. RTTNews

06:38AM EDT PerkinElmer (PKI) reported a profit for its second quarter that climbed from the same period last year. RTTNews

06:36AM EDT PerkinElmer Q2 GAAP EPS From Cont Opns $2.19 Vs $1.23 Last Year RTTNews

06:36AM EDT PerkinElmer Raises FY21 Adj. EPS Guidance From $9.40 To $9.88 vs $9.32 Est., Sees Adj. Revenue $4.57B vs $4.41B Est. Benzinga

06:34AM EDT PerkinElmer To Buy BioLegend For About $5.25 Bln In Cash And Stock Deal, Subject To Certain Adjustments RTTNews

06:34AM EDT PerkinElmer Sees Q3 Adj. EPS $1.62 vs $1.72 Est., Adj. Revenue $1B vs $983.73M Est. Benzinga

06:33AM EDT PerkinElmer Raises FY21 Guidance Benzinga

06:33AM EDT PerkinElmer Q2 Adj. EPS $2.83 Beats $2.41 Estimate, Sales $1.23B Beat $1.12B Estimate Benzinga

06:32AM EDT PerkinElmer Announces Financial Results for the Second Quarter of 2021 Business Wire

06:31AM EDT PerkinElmer Acquires BioLegend for $5.25B in Cash and Stock, BioLegend is a Provider of Antibodies and Reagents Benzinga

06:30AM EDT PerkinElmer to Acquire Antibody and Reagent Leader BioLegend Business Wire

Jul 23, 2021

04:27PM EDT PerkinElmer (PKI) Declares Quarterly Dividend of $ 0.07, Record Date 10/22/2021 RTTNews

04:24PM EDT PerkinElmer Declares Quarterly Dividend Of $0.07, Payable Nov. 12/record Oct. 22 RTTNews

04:15PM EDT PerkinElmer Board Declares Quarterly Dividend Business Wire

Jul 13, 2021

05:16PM EDT Parkland Corporation (Parkland) (TSX:PKI) announces that a dividend of $0.1029 per share will be paid on August 13, 2021 to shareholders of record on July 22, 2021. The dividend will be an 'eligible dividend' for Canadian income tax purposes. The ex-dividend date is July 21, 2021. GlobeNewswire Inc

Jul 6, 2021

07:30AM EDT Parkland strengthens its Quebec retail network with the GlobeNewswire Inc

Jun 24, 2021

06:05AM EDT PerkinElmer Expects To Exceed Prior Q2 Financial View RTTNews

06:00AM EDT PerkinElmer Provides Update on Second Quarter Performance and Schedules Earnings Call for Wednesday, July 28, 2021 Business Wire

Jun 22, 2021

08:15AM EDT PerkinElmer Inc. (PKI) agreed to buy SIRION Biotech GmbH, a provider of viral vector-based technologies that drive improved delivery performance for cell and gene therapies. The acquisition is expected to close during the third quarter of 2021. RTTNews

08:05AM EDT PerkinElmer To Acquire SIRION Biotech GmbH RTTNews

08:02AM EDT PerkinElmer To Acquire Viral Vector Gene Delivery Leader SIRION Biotech; Terms Not Disclosed Benzinga

08:00AM EDT PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader SIRION Biotech Business Wire

Jun 21, 2021

07:08PM EDT Parkland advances its track record of energy transition leadership GlobeNewswire Inc

Jun 11, 2021

05:03PM EDT Parkland Corporation (Parkland) (TSX:PKI) announces that a dividend of $0.1029 per share will be paid on July 15, 2021 to shareholders of record on June 22, 2021. The dividend will be an 'eligible dividend' for Canadian income tax purposes. The ex-dividend date is June 21, 2021. GlobeNewswire Inc

May 18, 2021

09:43AM EDT PerkinElmer Says Co's Oxford Immunotec's T-SPOT Discovery SARS-CoV-2 Test Is Used In UK COVID-19 Human Challenge Study To Investigate T Cell Response To SARS-CoV-2 Infection Benzinga

09:18AM EDT PerkinElmer Says Oxford Immunotec's T-SPOT Discovery SARS-CoV-2 Test Is Used In UK Study RTTNews

09:15AM EDT Oxford Immunotecs T-SPOT Discovery SARS-CoV-2 GlobeNewswire Inc

May 17, 2021

08:01AM EDT Parkland Corporation (Parkland, we, our, or the Company) (TSX:PKI) is pleased to announce, through its 75 percent ownership in Sol Investments SEZC (Sol), two transactions in our International business (the International transactions) which provide additional scale in the Caribbean and strengthen our position as a natural acquirer in the region. GlobeNewswire Inc

07:30AM EDT PerkinElmer To Acquire UK-Based In-Vitro Diagnostics Company For $155M Benzinga

02:15AM EDT PerkinElmer Announces Recommended All Cash Offer To Acquire Immunodiagnostic Systems Holdings PLC For $155 Mln RTTNews

02:12AM EDT PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC Business Wire

May 13, 2021

08:45AM EDT PerkinElmer Expands Into Cell Biology With $260M Nexcelom Bioscience Acquisition Benzinga

May 12, 2021

06:34PM EDT PerkinElmer, Inc. (PKI) Wednesday said it has acquired Nexcelom Bioscience for $260 million in cash. The transaction is expected to close during the second quarter of 2021. RTTNews

05:29PM EDT Parkland Corporation (Parkland) (TSX:PKI) announces that a dividend of $0.1029 per share will be paid on June 15, 2021 to shareholders of record on May 21, 2021. The dividend will be an 'eligible dividend' for Canadian income tax purposes. The ex-dividend date is May 20, 2021. GlobeNewswire Inc

04:23PM EDT PerkinElmer To Acquire Nexcelom Bioscience For $260M In Cash Benzinga

04:16PM EDT PerkinElmer Enters Agreement To Acquire Nexcelom Bioscience For $260 Mln RTTNews

04:05PM EDT PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience Business Wire

May 11, 2021

09:19AM EDT PerkinElmer Unit, Oxford Immunotec, Reports Its T-SPOT COVID Test Will Be Used For T Cell Testing In COVID Infection in Patients with Antibody Deficiency Study In Collab With University Of Birmingham Benzinga

09:15AM EDT Oxford Immunotecs T-SPOT.COVID Test is Used in GlobeNewswire Inc

May 4, 2021

05:29PM EDT PerkinElmer: Q1 Earnings Insights Benzinga

05:00PM EDT PerkinElmer to Host Virtual Investor and Analyst Day Business Wire

04:51PM EDT UPDATE: PerkinElmer Raises FY21 Guidance: Adj. EPS From $8.50+ To $9.40 vs $8.67 Estimate, GAAP Sales To $4.37B Benzinga

04:50PM EDT PerkinElmer Sees Q2 Adj. EPS $2.35 vs $2.35 Estimate, Sales ~$1.11B vs $1.07B Est. Benzinga

04:50PM EDT PerkinElmer Q1 Adj. EPS $3.72 Beats $3.07 Estimate, Sales $1.31B Beat $1.21B Estimate; Raises FY Guidance Benzinga

04:23PM EDT PerkinElmer (PKI) reported a profit for its first quarter that rose from last year. RTTNews

04:11PM EDT PerkinElmer Q1 GAAP EPS From Cont Ops $3.37 Vs $0.30 Last Year RTTNews

04:06PM EDT PerkinElmer Announces Financial Results for the First Quarter of 2021 Business Wire

10:07AM EDT P/E Ratio Insights for PerkinElmer Benzinga

May 3, 2021

05:22PM EDT Parkland Corporation ("Parkland", "we", the "Company", or "our") (TSX:PKI) announced today its financial and operating results for the three months ended March 31, 2021 ("Q1 2021"). Highlights include: GlobeNewswire Inc

04:13AM EDT Earnings Scheduled For May 3, 2021 Benzinga

Apr 29, 2021

04:19PM EDT PerkinElmer (PKI) Declares Quarterly Dividend of $ 0.07, Record Date 7/16/2021 RTTNews

04:15PM EDT PerkinElmer Board Declares Quarterly Dividend Business Wire

09:20AM EDT PerkinElmer's Oxford Immunotec Announces Its T-SPOT Discovery SARS-CoV-2 Test Will Be Used For T Cell Testing In The DIRECT Study To Investigate T Cell Response And COVID Vaccination In Ethnic Minority Groups Benzinga

09:15AM EDT Oxford Immunotecs T-SPOT Discovery SARS-CoV-2 GlobeNewswire Inc

Apr 21, 2021

08:00AM EDT PerkinElmer to Present at BofA Securities 2021 Virtual Health Care Conference Business Wire

Apr 15, 2021

05:07PM EDT Parkland Corporation (Parkland) (TSX:PKI) expects to announce its 2021 first quarter results after markets close on Monday, May 3, 2021. A conference call and webcast will then be held at 6:30 a.m. MDT (8:30 a.m. EDT) on Tuesday, May 4, 2021, to discuss the results. GlobeNewswire Inc

Apr 13, 2021

07:15PM EDT Parkland Corporation (Parkland) (TSX:PKI) announces that through its wholly owned U.S. subsidiaries (collectively, "Parkland USA"), it has completed the previously announced acquisition of Conrad & Bischoff Inc. and its related companies (collectively, C&B). GlobeNewswire Inc

05:22PM EDT Parkland Corporation (Parkland) (TSX:PKI) announced today the closing of its previously announced private offering (the offering) of US$800 million aggregate principal amount of 4.500% senior unsecured notes due 2029 (the notes). GlobeNewswire Inc

04:24PM EDT PerkinElmer Expects Q1 Revenue Growth Of 98% RTTNews

04:18PM EDT PerkinElmer Sees Reported Revenue Growth For Q1 Of 98%; Core (Non-COVID) Demand Up 10% Organically YoY Benzinga

04:18PM EDT PerkinElmer Expects Q1 Reported Sales Growth Of 98% And Organic Sales Growth Of 90% Benzinga

04:15PM EDT PerkinElmer Provides First Quarter Update and Schedules Earnings Call for Tuesday, May 4, 2021 Business Wire

Mar 29, 2021

07:47PM EDT Designated News Release Parkland Corporation (Parkland, "we", the "Company", or "our") (TSX:PKI) announced today a private offering of US$800 million aggregate principal amount of senior unsecured notes (the Offering). The notes will bear interest at 4.500% per annum and are due October 1, 2029. GlobeNewswire Inc

11:37AM EDT PerkinElmer's Horizon Discovery Says Extends Gene Modulation Portfolio With 'Industry First' Synthetic Single Guide RNA And Patent Pending dCas9 Repressor For CRISPR Interface Benzinga

11:33AM EDT Horizon Discovery Extends Gene Modulation Portfolio with Industry First Synthetic Single Guide RNA and Patent Pending dCas9 Repressor for CRISPR Interference Business Wire

Mar 11, 2021

05:06PM EST Parkland Corporation (Parkland) (TSX:PKI) announces that a dividend of $0.1029 per share will be paid on April 15, 2021 to shareholders of record on March 22, 2021. The dividend will be an 'eligible dividend' for Canadian income tax purposes. The ex-dividend date is March 19, 2021. GlobeNewswire Inc

Mar 9, 2021

09:17AM EST PerkinElmer Says Launching Comprehensive Solutions For Detecting SARS-CoV-2 Mutations Benzinga

08:04AM EST PerkinElmer Completes Acquisition Of Oxford Immunotec Global RTTNews

08:00AM EST PerkinElmer Launches Comprehensive Solutions for Detecting SARS-CoV-2 Mutations Business Wire

08:00AM EST PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC Business Wire

Mar 4, 2021

07:34PM EST PerkinElmer Says Prices Offering Of Senior Notes RTTNews

07:24PM EST PerkinElmer Prices Offering of Senior Notes Business Wire

05:15PM EST Parkland Corporation ("Parkland", "we", the "Company", or "our") (TSX:PKI) announced today its financial and operating results for the fourth quarter and year ended December 31, 2020 and 2021 outlook. Highlights include: GlobeNewswire Inc

02:29PM EST Oxford Immunotec Submits Emergency Use Authorization Request To FDA And CE Marks T-SPOT COVID Test For Detection Of A Cell Mediated Immune Response To COVID-19 Infection Benzinga

Feb 26, 2021

08:00AM EST Parkland announces acquisition of Conrad & Bischoff Inc., GlobeNewswire Inc

08:00AM EST PerkinElmer to Present at Barclays Global Healthcare Conference Business Wire

Feb 23, 2021

08:36AM EST PerkinElmer Announces 'Highly Sensitive' Point-Of-Care COVID-19 Antigen Test For Mass Screening Benzinga

08:12AM EST PerkinElmer Says Changes COVID-19 Rapid Testing Landscape With Point Of Care Antigen Test For Mass Screening RTTNews

08:00AM EST PerkinElmer Changes COVID-19 Rapid Testing Landscape with Highly Sensitive Point of Care Antigen Test for Mass Screening Business Wire

Feb 22, 2021

08:37AM EST PerkinElmer Provides Update On COVID-19 Valencia Branch Laboratory's Accreditation Process RTTNews

08:37AM EST PerkinElmer Offers Update On Accreditation Process For Its Valencia Branch Lab: VBL Receives Lab Field Service Routine Inspection Report On Feb. 19, 2021, Co. Has Til Mar. 1, 2021 To Respond Benzinga

08:30AM EST PerkinElmer Provides an Update on Valencia Branch Laboratory's Accreditation Process Business Wire

Feb 17, 2021

08:30PM EST Parkland Corporation ("Parkland", "we", the "Company", or "our") (TSX:PKI) today announced it co-processed approximately 44 million litres of Canadian-sourced canola and tallow bio-feedstocks in 2020 and aims to increasethis toup to 100 million litres in 2021. GlobeNewswire Inc

05:01PM EST Parkland Corporation (Parkland) (TSX:PKI) expects to announce its 2020 fourth quarter and year-end results after markets close on Thursday March 4, 2021. A conference call and webcast will then be held at 6:30 a.m. MST (8:30 a.m. EST) on Friday, March 5, 2021, to discuss the results. GlobeNewswire Inc

Feb 16, 2021

08:00AM EST PerkinElmer to Present at Cowen Health Care Conference Business Wire

07:00AM EST Organogenesis Appoints David C. Francisco as Chief Financial Officer GlobeNewswire Inc

Feb 11, 2021

05:14PM EST Parkland Corporation (Parkland) (TSX:PKI) announces that a dividend of $0.1012 per share will be paid on March 15, 2021 to shareholders of record on February 22, 2021. The dividend will be an 'eligible dividend' for Canadian income tax purposes. The ex-dividend date is February 19, 2021. GlobeNewswire Inc

Feb 9, 2021

03:29PM EST Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oxford Immunotec Global PLC - OXFD PR Newswire

Feb 2, 2021

04:31PM EST PerkinElmer (PKI) announced earnings for its fourth quarter that climbed from the same period last year. RTTNews

04:31PM EST PerkinElmer: Q4 Earnings Insights Benzinga

04:10PM EST PerkinElmer Q4 EPS $3.38 Vs. $0.58 Year Ago RTTNews

04:08PM EST PerkinElmer Sees Q1 Adj. EPS $3.00+ vs $2.40 Est., Sales $1.19B+ vs $1.1B Est.; Sees FY21 Adj. EPS $8.50+ vs $8.88 Est., Sales $4.08B+ vs $4.17B Est. Benzinga

04:06PM EST PerkinElmer Q4 Adj. EPS $3.96 Beats $3.00 Estimate, Sales $1.35B Beat $1.22B Estimate Benzinga

04:05PM EST PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2020 Business Wire

04:00AM EST Earnings Scheduled For February 2, 2021 Benzinga

Feb 1, 2021

10:05AM EST PerkinElmer's Earnings: A Preview Benzinga

Jan 28, 2021

04:18PM EST PerkinElmer (PKI) Declares Quarterly Dividend of $ 0.07, Record Date 4/16/2021 RTTNews

04:15PM EST PerkinElmer Board Declares Quarterly Dividend Business Wire

Jan 20, 2021

06:03PM EST SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of GlobeNewswire Inc

Jan 14, 2021

08:22AM EST PerkinElmer, Inc. (PKI) announced Thursday that its PerkinElmer New Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) to test individuals without symptoms or other reasons to suspect COVID-19 infection. RTTNews

08:06AM EST PerkinElmer SARS-CoV-2 RT-PCR Assay Receives FDA EUA for Asymptomatic Testing Benzinga

08:04AM EST PerkinElmer SARS-CoV-2 RT-PCR Assay Gets FDA EUA For Asymptomatic Testing RTTNews

08:01AM EST PerkinElmer SARS-CoV-2 RT-PCR Assay Receives FDA EUA for Asymptomatic Testing Business Wire

Jan 13, 2021

05:30PM EST Parkland Corporation (Parkland) (TSX:PKI) announces that a dividend of $0.1012 per share will be paid on February 15, 2021 to shareholders of record on January 22, 2021. The dividend will be an 'eligible dividend' for Canadian income tax purposes. The ex-dividend date is January 21, 2021. GlobeNewswire Inc

Jan 11, 2021

06:18AM EST Healthcare company PerkinElmer, Inc. (PKI) announced Monday that it expects reported and organic revenue growth of approximately 66% and 63%, respectively, earnings per share from continuing operations of at least $2.88, and adjusted earnings per share from continuing operations of at least $3.60 for the fourth quarter. RTTNews

06:11AM EST PerkinElmer Sees Q4 EPS At least $3.60 Vs. $2.79 Est. Benzinga

06:05AM EST PerkinElmer Anticipates Q4 Reported And Organic Revenue Growth Of 66% And 63%, Respectively RTTNews

06:00AM EST PerkinElmer Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, February 2, 2021 Business Wire

Jan 8, 2021

07:25AM EST The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs Benzinga

Jan 7, 2021

12:10PM EST Benzinga's Top Upgrades, Downgrades For January 7, 2021 Benzinga

07:37AM EST Wells Fargo Upgrades PerkinElmer to Overweight, Raises Price Target to $175 Benzinga

07:16AM EST PerkinElmer, Inc. (PKI) and Oxford Immunotec Global PLC (OXFD) have reached an agreement on terms under which PerkinElmer will acquire Oxford Immunotec. Oxford shareholders will be entitled to receive $22.00 in cash for each outstanding ordinary share. This value the company's entire issued and to be issued ordinary share capital at approximately $591 million. RTTNews

07:05AM EST PerkinElmer To Acquire Oxford Immunotec RTTNews

07:01AM EST PerkinElmer to Acquire Oxford Immunotec Global PLC For $22/Share In Cash Benzinga

07:00AM EST PerkinElmer to Acquire Oxford Immunotec Global PLC Business Wire

Dec 16, 2020

08:00AM EST PerkinElmer to Present at J.P. Morgan Healthcare Conference Business Wire

Dec 11, 2020

05:01PM EST Parkland Corporation (Parkland) (TSX:PKI) announces that a dividend of $0.1012 per share will be paid on January 15, 2021 to shareholders of record on December 22, 2020. The dividend will be an 'eligible dividend' for Canadian income tax purposes. The ex-dividend date is December 21, 2020. GlobeNewswire Inc

Dec 3, 2020

05:01PM EST Parkland Corporation (Parkland, we, our, or the Company) (TSX:PKI) is pleased to announce that through its wholly owned U.S. subsidiaries (collectively, "Parkland USA"), it has entered into a series of transactions (the Acquisitions) to acquire: GlobeNewswire Inc

Dec 2, 2020

01:12PM EST 'Halftime Report' Final Trades: Ulta, Google And More Benzinga

Nov 19, 2020

05:01PM EST Parkland Corporation ("Parkland", "we", the "Company", or "our") (TSX:PKI) is pleased to announce the appointment of Marcel Teunissen as Chief Financial Officer (CFO), effective December 1, 2020. GlobeNewswire Inc

Nov 17, 2020

08:00AM EST PerkinElmer to Host Virtual Life Science Event Business Wire

Nov 12, 2020

08:12AM EST PerkinElmer SARS-CoV-2 RT-PCR Assay Receives CE Mark for Saliva and Sample Pooling to Test Symptomatic and Asymptomatic Individuals Benzinga

08:08AM EST PerkinElmer SARS-CoV-2 RT-PCR Assay Gets CE Mark For Saliva,Sample Pooling To Test Symptomatic &Asymptomatic Individuals RTTNews

08:00AM EST PerkinElmer SARS-CoV-2 RT-PCR Assay Receives CE Mark for Saliva and Sample Pooling to Test Symptomatic and Asymptomatic Individuals Business Wire

Nov 11, 2020

05:03PM EST Parkland Corporation (Parkland) (TSX:PKI) announces that a dividend of $0.1012 per share will be paid on December 15, 2020 to shareholders of record on November 20, 2020. The dividend will be an 'eligible dividend' for Canadian income tax purposes. The ex-dividend date is November 19, 2020. GlobeNewswire Inc

Nov 10, 2020

09:31AM EST Benzinga's Top Upgrades, Downgrades For November 10, 2020 Benzinga

Nov 9, 2020

08:42AM EST PerkinElmer Subsidiary EUROIMMUN Launches Quantitative ELISA To Measure SARS-CoV-2 Antibodies Against Viral S1 Protein Benzinga

08:31AM EST 10 Biggest Price Target Changes For Monday Benzinga

08:07AM EST PerkinElmer: EUROIMMUN Launches Quantitative ELISA To Measure SARS-CoV-2 Antibodies Against Viral S1 Protein RTTNews

08:03AM EST Needham Maintains Buy on PerkinElmer, Raises Price Target to $193 Benzinga

08:00AM EST EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 Protein Business Wire

Nov 5, 2020

08:00AM EST PerkinElmer to Present at Wolfe Virtual Healthcare Conference Business Wire

Nov 3, 2020

06:34PM EST Parkland Corporation ("Parkland", "we", the "Company", or "our") (TSX:PKI) announced today its financial and operating results for the three and nine months ended September 30, 2020. Highlights from the third quarter (unless otherwise indicated) include: GlobeNewswire Inc

Nov 2, 2020

02:46AM EST PerkinElmer To Buy Horizon Discovery For $383 Mln; Transaction To Close In Q1 2021 RTTNews

02:05AM EST PerkinElmer to Acquire Cell Engineering Company Horizon Discovery for $383 Million (296 Million) Business Wire

Oct 29, 2020

04:29PM EDT PerkinElmer COVID-19 Test Kit Receives FDA Emergency Use Authorization for Sample Pooling Benzinga

10:02AM EDT Wells Fargo Maintains Equal-Weight on PerkinElmer, Raises Price Target to $140 Benzinga

Oct 28, 2020

04:58PM EDT PerkinElmer (PKI) revealed earnings for its third quarter that climbed from last year. RTTNews

04:31PM EDT PerkinElmer Sees Q4 EPS $2.60-$3.00 Vs. $1.81 Est., Sales $1.12B-$1.23B Vs. $939.69M Est. Benzinga

04:29PM EDT PerkinElmer Q3 EPS $2.09 Beats $1.50 Estimate, Sales $964.02M Beat $841.19M Estimate Benzinga

04:22PM EDT PerkinElmer Q3 EPS $1.57 Vs. $0.52 Year Ago RTTNews

04:05PM EDT PerkinElmer Announces Financial Results for the Third Quarter of 2020 Business Wire

Oct 26, 2020

08:26AM EDT PerkinElmer, Inc. (PKI) said Monday that its PKamp Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro diagnostic or IVD device in more than 30 countries as it met the requirements of the European In Vitro Diagnostic Directive or IVDD. RTTNews

08:07AM EDT PerkinElmer Reports Receives CE Mark, Multi-Analyte Respiratory Panel Including COVID-19 Benzinga

08:06AM EDT PerkinElmer Gets CE Mark For PKamp Respiratory SARS-CoV-2 RT-PCR Panel RTTNews

08:00AM EDT PerkinElmer Receives CE Mark for Multi-analyte Respiratory Panel Including COVID-19 Business Wire

Oct 22, 2020

04:22PM EDT PerkinElmer (PKI) Declares Quarterly Dividend of $ 0.07, Record Date 1/22/2021 RTTNews

04:15PM EDT PerkinElmer Board Declares Quarterly Dividend Business Wire

Oct 20, 2020

05:01PM EDT Parkland Corporation (Parkland) (TSX:PKI) expects to announce its 2020 third quarter results after markets close on Tuesday, November 3, 2020. A conference call and webcast will then be held at 6:30 a.m. MDT (8:30 a.m. EDT) on Wednesday, November 4, 2020, to discuss the results. GlobeNewswire Inc

09:06AM EDT PerkinElmer: Research Team At NCATS Of NIH Is Working With Its AlphaLISA Immunoassay For Effective COVID-19 Therapeutics RTTNews

09:04AM EDT PerkinElmer Reports Research Team At National Institutes Of Health's National Center For Advancing Translational Sciences Is Working With Co.'s AlphaLISA Immunoassay To Help Support Search For Effective COVID-19 Therapeutics Benzinga

09:00AM EDT PerkinElmer Immunoassay Helps NIH NCATS Team Identify Therapeutic Compounds Capable of Disrupting the SARS-CoV-2 Spike Protein/ACE2 Interaction Business Wire

Oct 13, 2020

06:28PM EDT Parkland Corporation (Parkland) (TSX:PKI) announces that a dividend of $0.1012 per share will be paid on November 13, 2020 to shareholders of record on October 22, 2020. The dividend will be an 'eligible dividend' for Canadian income tax purposes. The ex-dividend date is October 21, 2020. GlobeNewswire Inc

Oct 12, 2020

10:09AM EDT CORRECTING and REPLACING PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020 Business Wire

08:22AM EDT PerkinElmer, Inc. (PKI) said the company expects reported and organic revenue growth of approximately 35% and 33%, respectively, for the third quarter. COVID-19 related solutions generated approximately $280 million of revenue in the third quarter. RTTNews

08:07AM EDT PerkinElmer Expects Reported And Organic Revenue Growth Of About 35% And 33%, Respectively, For Q3 RTTNews

08:01AM EDT PerkinElmer Expects Q3 Reported And Organic Revenue Growth Of Approximately 35% And 33% Benzinga

08:00AM EDT PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020 Business Wire

Sep 30, 2020

05:01PM EDT Parkland releases inaugural Sustainability Report GlobeNewswire Inc

Sep 11, 2020

05:08PM EDT Parkland Corporation (Parkland) (TSX:PKI) announces that a dividend of $0.1012 per share will be paid on October 15, 2020 to shareholders of record on September 22, 2020. The dividend will be an 'eligible dividend' for Canadian income tax purposes. The ex-dividend date is September 21, 2020. GlobeNewswire Inc

09:38AM EDT Benzinga's Top Upgrades, Downgrades For September 11, 2020 Benzinga

06:37AM EDT Needham Upgrades PerkinElmer to Buy, Announces $139 Price Target Benzinga

Sep 10, 2020

05:01PM EDT Parkland Corporation ("Parkland", "we", the "Company", or "our") (TSX:PKI) announced it has acquired the license for the exclusive use of the On the Run trademark in the majority of U.S. states. The acquisition positions Parkland to expand On the Run across the U.S. to create a unified, North American convenience store brand. GlobeNewswire Inc

Sep 4, 2020

08:00AM EDT PerkinElmer to Present at BofA Global Healthcare Conference 2020 Business Wire

Sep 2, 2020

01:41PM EDT The Pure US Cannabis ETF Started Trading Today: Here Are Its Holdings Benzinga

Aug 26, 2020

03:24PM EDT California Governor Newsom Says Will Release New Reopening Guidelines On Friday; Says State Working With Perkinelmer To Expand Virus Testing Benzinga

Aug 19, 2020

04:15PM EDT PerkinElmer to Present at Baird's 2020 Virtual Global Healthcare Conference Business Wire

Aug 17, 2020

04:31PM EDT PerkinElmer, Inc. (PKI) Monday said its Hand Sanitizer Analyzer instrument can be used to test for the presence of methanol in alcohol-based hand sanitizer products with pass/fail results delivered in 30 seconds or less. RTTNews

10:48AM EDT PerkinElmer Says Enhances Hand Sanitizer Analyzer To Detect Methanol In 30 Seconds Or Less RTTNews

10:39AM EDT PerkinElmer Enhances Hand Sanitizer Analyzer to Detect Methanol in 30 Seconds or Less Business Wire

09:02AM EDT PerkinElmer Launches Modular And Scalable Explorer Workstations For 'High-throughput COVID-19 Detection' Benzinga

09:00AM EDT PerkinElmer Launches Modular and Scalable explorer(tm) Workstations for High-throughput COVID-19 Detection Business Wire

Aug 12, 2020

05:05PM EDT Parkland Corporation (Parkland) (TSX:PKI) announces that a dividend of $0.1012 per share will be paid on September 15, 2020 to shareholders of record on August 21, 2020. The dividend will be an 'eligible dividend' for Canadian income tax purposes. The ex-dividend date is August 20, 2020. GlobeNewswire Inc

Aug 3, 2020

02:21PM EDT 'Fast Money Halftime Report' Picks For August 3: Aptiv, GLD And More Benzinga

Jul 29, 2020

02:10PM EDT JP Morgan Maintains Neutral on PerkinElmer, Raises Price Target to $105 Benzinga

11:01AM EDT Stifel Maintains Buy on PerkinElmer, Raises Price Target to $125 Benzinga

Jul 28, 2020

04:31PM EDT PerkinElmer (PKI) released a profit for its second quarter that increased from last year. RTTNews

Share